In this study, we used an updated version of a previously established database (Györffy et al. 2010; Mihály et al. 2013) incorporating the gene expression data of over three thousand breast cancer patients to determine whether the expression of glypicans has an impact on relapse-free survival (RFS). Here, GPC1 is linked to breast cancer.